There has been an explosion of knowledge about treatment of COVID-19 in the community, with various updates affecting Australian general practice. Earlier this year the PBAC updated their recommendations again. Across four short, sharp and topical MEDTalks, a vibrant, passionate panel of GPs and an epidemiologist will outline the latest considerations for GPs when deciding which COVID treatment to use, on whom, and when.

Eosinophilic oesophagitis (EoE) is a differential diagnosis in adults presenting with symptoms of oesophageal dysfunction, such as difficulty or pain when swallowing. Learn how to differentiate between EoE and gastro-oesophageal reflux disease, and when to refer to a gastroenterologist.

This on-demand webinar, presented by A/Prof Michael Woodward, Prof Grant Waterer and Dr Victoria Hayes will equip GPs to understand the prevalence, seasonal patterns, and demographic impacts of RSV in Australia. It also outlines preventative measures in older age groups, including safety and efficacy features of the new RSV vaccine for adults.

In this clinical audit, you will identify patients with COPD who have a history of moderate to severe exacerbations in the past 12 months and an increased risk of cardiovascular events. You will consider how your patient’s self-management behaviours, inhaled COPD medications and prescribed non-pharmacological treatments could be further optimised, in line with evidence-based guidelines, to improve symptom control and reduce the risk of further exacerbations.

This module aims to increase GPs’ understanding of when to step up treatment for acute migraine, and how to help patients access and use medications effectively and appropriately to treat acute migraine.